Ganesh S - Search Results

1

Urokinase receptor and colorectal cancer survival.

Ganesh S, Sier CF, Heerding MM, Griffioen G, Lamers CB, Verspaget HW. Ganesh S, et al. Lancet. 1994 Aug 6;344(8919):401-2. doi: 10.1016/s0140-6736(94)91427-3. Lancet. 1994. PMID: 7914317 No abstract available.

2

Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.

Verspaget HW, Sier CF, Ganesh S, Griffioen G, Lamers CB. Verspaget HW, et al. Among authors: ganesh s. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1105-9. doi: 10.1016/0959-8049(95)00170-n. Eur J Cancer. 1995. PMID: 7577001 Review.

3

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

Sier CF, Quax PH, Vloedgraven HJ, Verheijen JH, Griffioen G, Ganesh S, Lamers CB, Verspaget HW. Sier CF, et al. Among authors: ganesh s. Invasion Metastasis. 1993;13(6):277-88. Invasion Metastasis. 1993. PMID: 7860221

4

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis.

Sier CF, Vloedgraven HJ, Ganesh S, Griffioen G, Quax PH, Verheijen JH, Dooijewaard G, Welvaart K, van de Velde CJ, Lamers CB, et al. Sier CF, et al. Among authors: ganesh s. Gastroenterology. 1994 Nov;107(5):1449-56. doi: 10.1016/0016-5085(94)90549-5. Gastroenterology. 1994. PMID: 7926508

5

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, van de Velde CJ, van Krieken JH, Verheijen JH, Lamers CB, et al. Ganesh S, et al. Cancer Res. 1994 Aug 1;54(15):4065-71. Cancer Res. 1994. PMID: 8033138

6

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Br J Cancer. 1997;75(12):1793-801. doi: 10.1038/bjc.1997.306. Br J Cancer. 1997. PMID: 9192984 Free PMC article.

7

Clinical applications of the urokinase receptor (uPAR) for cancer patients.

Boonstra MC, Verspaget HW, Ganesh S, Kubben FJ, Vahrmeijer AL, van de Velde CJ, Kuppen PJ, Quax PH, Sier CF. Boonstra MC, et al. Among authors: ganesh s. Curr Pharm Des. 2011;17(19):1890-910. doi: 10.2174/138161211796718233. Curr Pharm Des. 2011. PMID: 21711239 Review.

8

Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.

Mulder TP, Verspaget HW, Sier CF, Roelofs HM, Ganesh S, Griffioen G, Peters WH. Mulder TP, et al. Among authors: ganesh s. Cancer Res. 1995 Jun 15;55(12):2696-702. Cancer Res. 1995. PMID: 7780987

9

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

Sier CF, Verspaget HW, Griffioen G, Ganesh S, Vloedgraven HJ, Lamers CB. Sier CF, et al. Among authors: ganesh s. Gut. 1993 Jan;34(1):80-5. doi: 10.1136/gut.34.1.80. Gut. 1993. PMID: 8432457 Free PMC article.

10

Prognostic value of the plasminogen activation system in patients with gastric carcinoma.

Ganesh S, Sier CF, Heerding MM, van Krieken JH, Griffioen G, Welvaart K, van de Velde CJ, Verheijen JH, Lamers CB, Verspaget HW. Ganesh S, et al. Cancer. 1996 Mar 15;77(6):1035-43. doi: 10.1002/(sici)1097-0142(19960315)77:6<1035::aid-cncr5>3.0.co;2-g. Cancer. 1996. PMID: 8635120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

927 results

Search Page